Drugs such as PD-L1 inhibitors stimulate cytotoxic CD8 T cells, enabling them to engage with and destroy tumors by removing immunosuppressive signals in the tumor microenvironment [3–5]. This evidence concerns the gene CD8A and neoplasm.